Shanghai Securities News China Securities Network News (reporter Confucius Ziyuan) Kang enbei announced that the company's holding subsidiary Jinhua Kangbei received the "Notice of Approval of Drug Supplement Application" issued by the State Food and Drug Administration for parecoxib sodium for injection, and the drug passed the consistency evaluation of generic drugs. Indications for parecoxib sodium for injection are short-term treatments for postoperative pain, exert anti-inflammatory analgesic effects by specifically inhibiting COX-2 to block arachidonic acid synthesis of prostaglandins, and can reduce the dosage of anesthetic analgesics.
![Announcement #ONLICOM: Levoclodipine besylate tablets passed the generic drug consistency evaluation[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)